Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-44,994
Closed -$2.08M 368
2015
Q3
$2.08M Sell
44,994
-4,940
-10% -$280K 0.42% 72
2015
Q2
$3.11M Sell
49,934
-1,259
-2% -$80.4K 0.57% 57
2015
Q1
$3.2M Buy
51,193
+661
+1% +$44.4K 0.59% 51
2014
Q4
$3.2M Buy
50,532
+1,783
+4% +$118K 0.61% 53
2014
Q3
$3.36M Sell
48,749
-160
-0.3% -$11.6K 0.65% 52
2014
Q2
$3.29M Buy
48,909
+1,482
+3% +$96.2K 0.6% 55
2014
Q1
$2.89M Buy
47,427
+1,996
+4% +$120K 0.51% 63
2013
Q4
$2.73M Buy
+45,431
New +$2.89M 0.6% 63

Other funds holding PHI

Stanley-Laman Group's PHI Position: Q4 2015 in Review

Stanley-Laman Group sold out of PLDT (PHI) in Q4 2015, closing a stake of 44,994 shares — an estimated $2.08M sold.

Stanley-Laman Group first reported a position in PHI in Q4 2013 and held it in 8 quarters. The position peaked at $3.36M in Q3 2014. 83 funds tracked by Wall St. Rank hold PHI as of Q4 2015.

  • Stanley-Laman Group reported no remaining PLDT position as of Q4 2015 after selling out during the quarter.
  • Stanley-Laman Group sold 44,994 PLDT shares in Q4 2015, an estimated $2.08M.
  • Stanley-Laman Group first reported a position in PLDT in Q4 2013 and held it in 8 quarters.
  • Stanley-Laman Group's PLDT position peaked at $3.36M in Q3 2014.
  • 83 funds tracked by Wall St. Rank held PLDT as of Q4 2015.

Based on Stanley-Laman Group's 13F filing for Q4 2015, filed 26 Jan 2016.